Zobrazeno 1 - 10
of 125
pro vyhledávání: '"linfomi"'
Autor:
Simone Ferrero, Daniele Grimaldi, Elena Arrigoni, Mariapia Pironti, Gian Maria Zaccaria, Beatrice Alessandria, Elisa Genuardi, Gabriele De Luca, Marco Ghislieri, Rita Tavarozzi, Alice Di Rocco, Alessandro Re, Vittorio Stefoni, Federica Cavallo, Carola Boccomini, Monica Balzarotti, Vittorio Ruggero Zilioli, Filipa Moita, Luca Arcaini, Elisa Lucchini, Filippo Ballerini, Andrés J. M. Ferreri, Benedetta Puccini, Giuseppe A Palumbo, Sara Galimberti, Sergio Cortelazzo, Antonello Di Paolo, Marco Ladetto
Publikováno v:
Blood Advances.
In the FIL MCL0208 phase III trial, lenalidomide maintenance (LEN) after transplantation (ASCT) in mantle cell lymphoma (MCL) improved progression-free survival (PFS) vs observation (OBS). The host pharmacogenetic background was analyzed to decipher
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a765e9b39125850fdd7d36293ae9027a
https://doi.org/10.1182/bloodadvances.2022009504
https://doi.org/10.1182/bloodadvances.2022009504
Autor:
Hugo J. A. Adams, Thomas C. Kwee
Publikováno v:
Seminars in Oncology. 44:404-419
Assessing response to therapy in lymphoma is important for determining patients' prognosis, guiding subsequent treatment, and may be used as an outcome measure of prognostic and therapeutic trials. Traditionally, computed tomography was the mainstay
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d8147fa1b65da34a91d53d16ca0d539
https://doi.org/10.1053/j.seminoncol.2018.01.005
https://doi.org/10.1053/j.seminoncol.2018.01.005
Publikováno v:
Seminars in oncology. 44(6):404-419
Assessing response to therapy in lymphoma is important for determining patients' prognosis, guiding subsequent treatment, and may be used as an outcome measure of prognostic and therapeutic trials. Traditionally, computed tomography was the mainstay
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___01423::c7d9ace15c3f9d7e44f36ebee4dc72be
https://research.rug.nl/en/publications/5936bb6a-1941-4cd1-9f73-33ba7376c1de
https://research.rug.nl/en/publications/5936bb6a-1941-4cd1-9f73-33ba7376c1de
Autor:
Cimino, C., Carraro, E., Mussolin, L., D’Amore, E. S., Buffardi, S., Garaventa, A., Lombardi, A., De Santis, R., D’Angelo, P., Bulian, P., Santoro, N., Porta, F., Mura, R., Tondo, A., Cellini, M., Sala, A., Bertolini, P., Perruccio, K., Nardi, M., Piglione, M., Cesaro, Simone, Pillon, M., Lo Nigro, L.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1943::32de469bbb74a1cd4181874d86446184
http://hdl.handle.net/11562/945381
http://hdl.handle.net/11562/945381
Autor:
ALBANO, Domenico, Patti, C., LA GRUTTA, Ludovico, LAGALLA, Roberto, MIDIRI, Massimo, GALIA, Massimo
Scopo Scopo del nostro studio è stato quello di comparare la RM whole body (RM-WB) con la PET/TC nella stadiazione dei linfomi FDG-avidi. Materiale e metodi 68 pazienti (37 maschi, età mediana 42 anni, range 15-86) con diagnosi istologica di Linfom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3658::795ccf4e60939cf0e6baa8994da68c2c
http://hdl.handle.net/10447/204417
http://hdl.handle.net/10447/204417
Autor:
M. Ponzoni, P. Vezzoli, Silvia Govi, Arianna Vino, Fabio Facchetti, Anna Ferreri, Riccardo Dolcetti, Elisa Pasini, Claudio Doglioni, Silvia Mappa, Emilio Berti
Publikováno v:
British Journal of Dermatology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab0c096a808bcc0bae3a457a693d21e0
Autor:
PICCALUGA, PIER PAOLO
Epidemiologia I linfomi a cellule T-periferiche (LCTP) rappresentano approssimativamente il 10-15% dei linfomi non Hodgkin (LNH). I LCTP sono un gruppo eterogeneo di neoplasie che la classificazione WHO suddivide grossolanamente in forme specifiche e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::02d371c59e8aa79974d0939d05ed6b9c
http://hdl.handle.net/11585/122709
http://hdl.handle.net/11585/122709